Status and phase
Conditions
Treatments
About
Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients with Chronic Lymphocytic Leukemia
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
247 participants in 2 patient groups, including a placebo group
There are currently no registered sites for this trial.
Central trial contact
Patrick M Murphy
Start date
Oct 05, 2020 • 4 years ago
Today
Apr 30, 2025
End date
Oct 01, 2025 • in 5 months
Lead Sponsor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal